Bon Natural Life (BON) AI Stock Analysis

131 Followers

Bon Natural Life

(NASDAQ:BON)

Select Model

Rating:51Neutral

Price Target:$1.00▼(-9.09% Downside)

Action:reiterated

Date:06/11/26

The overall score of 51 reflects significant financial challenges, including declining revenues, losses, and cash burn. While recent technical momentum offers some short-term optimism, overbought conditions and high volatility temper the outlook. Valuation remains unattractive due to negative earnings. Investors should approach with caution.

Positive Factors

Manageable LeverageLow leverage provides some financial flexibility and reduces balance-sheet strain relative to a highly indebted business. This buffer may help Bon Natural Life fund operations while it works to restore profitability and cash generation.

Negative Factors

Revenue and Margin DeteriorationThe simultaneous decline in sales and gross margin indicates weakening operating momentum and reduced earnings quality. Unless demand and pricing recover, lower scale and profitability can constrain reinvestment and make a durable recovery more difficult.

Bon Natural Life (BON) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $6.74M
Dividend Yield: ―
Average Volume (3M): 8,821
Price to Earnings (P/E): -0.5
Beta (1Y): 1.61
Revenue Growth: -12.92%
EPS Growth: -173.30%
Country: US
Employees: 96
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals - Specialty

Bon Natural Life Business Overview & Revenue Model

Company Description

Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of Chin...

How the Company Makes Money

null

Bon Natural Life Financial Statement Overview

Summary

Revenue decline, margin contraction, net losses, and negative free cash flow indicate deteriorating financial health. Balance sheet shows moderate leverage but profitability concerns remain.

Income Statement

20Very Negative

Balance Sheet

35Negative

Cash Flow

15Very Negative

Financial statement breakdown
Breakdown	TTM	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	18.82M	18.67M	23.84M	29.52M	29.91M	25.49M
Gross Profit	4.16M	3.88M	7.11M	8.84M	9.42M	7.11M
EBITDA	-6.96M	-57.83K	2.30M	6.98M	8.38M	6.13M
Net Income	-11.37M	-1.99M	398.17K	4.60M	6.24M	4.59M
Balance Sheet
Total Assets	80.20M	85.19M	61.77M	46.56M	37.26M	36.41M
Cash, Cash Equivalents and Short-Term Investments	9.18M	6.27M	80.47K	111.30K	840.86K	3.61M
Total Debt	12.33M	12.32M	7.30M	4.21M	5.41M	3.21M
Total Liabilities	29.42M	27.19M	17.42M	10.57M	7.16M	9.88M
Stockholders Equity	50.78M	57.55M	43.91M	35.48M	29.56M	26.01M
Cash Flow
Free Cash Flow	2.20M	-4.23M	-7.73M	-713.82K	-4.92M	-700.78K
Operating Cash Flow	10.86M	141.12K	-7.72M	-651.91K	-187.12K	4.05M
Investing Cash Flow	-14.28M	-10.00M	-15.73K	-1.19M	-3.06M	-7.44M
Financing Cash Flow	3.50M	15.45M	8.76M	1.16M	2.26M	5.35M

Bon Natural Life Technical Analysis

Technical Analysis SentimentNegative

Last Price1.10

Price Trends

50DMA1.15Negative

100DMA1.15Negative

200DMA1.27Negative

Market Momentum

MACD-0.01Positive

RSI40.70Neutral

STOCH77.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BON, the sentiment is Negative. The current price of 1.10 is below the 20-day moving average (MA) of 1.13, below the 50-day MA of 1.15, and below the 200-day MA of 1.27, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 40.70 is Neutral, neither overbought nor oversold. The STOCH value of 77.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BON.

Bon Natural Life Risk Analysis

Bon Natural Life disclosed 48 risk factors in its most recent earnings report. Bon Natural Life reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk

1.Because we conduct all of our operations in China, our business is subject to the complex and rapidly evolving laws and regulations there. The Chinese government may exercise significant oversight and discretion over the conduct of our business and may intervene in or influence our operations at any time, which could result in a material change in our operations and/or the value of our Ordinary Shares, could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or be worthless.Q3, 2023

Bon Natural Life Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

BON against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
BON	51Neutral	$9.23M	-0.48	-20.98%	―	-12.92%	-173.30%
LSF	48Neutral	$30.44M	-9.33	-0.17%	―	129.59%	-31.22%
FAMI	45Neutral	$4.31M	-0.00	-77.20%	―	-58.43%	-252.50%
NAII	39Underperform	$5.96M	-0.26	-33.23%	―	9.08%	-52.59%

* Basic Materials Sector Average

Performance Comparison

BON and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
BON	Bon Natural Life Limited	1.10	-0.66	-37.50%
PLAG	Planet Green Holdings Corp	0.38	-1.34	-77.97%
NAII	Natural Alternatives International	0.97	-1.99	-67.36%
FAMI	Farmmi	0.10	-1.46	-93.46%
LSF	Laird Superfood, Inc.	2.52	0.01	0.40%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jun 11, 2026

Bon Natural Life AI Stock Analysis